Physician profile
Steven Moore
NPI 1982678108
$511.82
in general payments reported to CMS, 2019-2025
14 companies · $35.06 in 2025
The $35.06 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $37.10 · 2022: $207 · 2023: $27.63 · 2024: $79.60 · 2025: $35.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.23 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $125.00 | 2019 | |
| Antares Pharma, INC. | $90.55 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $57.13 | 2024 | Axonics |
| Srs Medical Systems, INC. | $40.25 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Travere Therapeutics, INC. | $25.76 | 2021 | |
| Urogen Pharma, INC. | $23.83 | 2022 | |
| Convatec INC. | $22.66 | 2022 | |
| Blue Earth Diagnostics | $22.47 | 2024 | |
| Myovant Sciences INC. | $17.12 | 2022 | |
| Teleflex LLC | $14.62 | 2022 | |
| Sumitomo Pharma America, INC. | $13.45 | 2023 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $12.58 | 2022 | |
| Coloplast Corp | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.